Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Read MoreBreaking News, World Updates & Headlines
Breaking News, World Updates & Headlines
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Read MoreModerna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
Read MoreNew therapies are transforming the treatment of the skin cancer, which can be deadly.
Read More